This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3299) Telehealth and Telemonitoring (1671) Home Care (170) Innovations and Technology in Cancer Care (423) Fitness Trackers and Smart Pedometers/Accelerometers (561)

Published on in Vol 18, No 11 (2016): November

Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project

Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project

Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project

Authors of this article:

Pasquale F Innominato1, 2, 3 Author Orcid Image ;   Sandra Komarzynski1, 3 Author Orcid Image ;   Ali Mohammad-Djafari4 Author Orcid Image ;   Alexandre Arbaud3 Author Orcid Image ;   Ayhan Ulusakarya3, 5 Author Orcid Image ;   Mohamed Bouchahda3, 5, 6 Author Orcid Image ;   Mazen Haydar5 Author Orcid Image ;   Rachel Bossevot-Desmaris5 Author Orcid Image ;   Virginie Plessis5 Author Orcid Image ;   Magali Mocquery5 Author Orcid Image ;   Davina Bouchoucha5 Author Orcid Image ;   Mehran Afshar7 Author Orcid Image ;   Jacques Beau3 Author Orcid Image ;   Abdoulaye Karaboué3, 8 Author Orcid Image ;   Jean-François Morère5, 9 Author Orcid Image ;   Joanna Fursse10 Author Orcid Image ;   Jordi Rovira Simon11 Author Orcid Image ;   Francis Levi1, 2, 3, 5 Author Orcid Image
Article Authors Cited by (23) Tweetations (8) Metrics

Journals

  1. Hofmeister E, Fisher S, Palesh O, Innominato P. Does circadian rhythm influence gastrointestinal toxicity?. Current Opinion in Supportive & Palliative Care 2020;14(2):120 View
  2. Lévi F, Komarzynski S, Huang Q, Young T, Ang Y, Fuller C, Bolborea M, Brettschneider J, Fursse J, Finkenstädt B, White D, Innominato P. Tele-Monitoring of Cancer Patients’ Rhythms during Daily Life Identifies Actionable Determinants of Circadian and Sleep Disruption. Cancers 2020;12(7):1938 View
  3. Innominato P, Komarzynski S, Karaboué A, Ulusakarya A, Bouchahda M, Haydar M, Bossevot-Desmaris R, Mocquery M, Plessis V, Lévi F. Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home—Results From a Pilot Study. JCO Clinical Cancer Informatics 2018;(2):1 View
  4. Innominato P, Komarzynski S, Palesh O, Dallmann R, Bjarnason G, Giacchetti S, Ulusakarya A, Bouchahda M, Haydar M, Ballesta A, Karaboué A, Wreglesworth N, Spiegel D, Lévi F. Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer. Cancer Medicine 2018;7(9):4396 View
  5. Komarzynski S, Huang Q, Lévi F, Palesh O, Ulusakarya A, Bouchahda M, Haydar M, Wreglesworth N, Morère J, Adam R, Innominato P. The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project). Sleep 2019;42(10) View
  6. Innominato P, Ballesta A, Huang Q, Focan C, Chollet P, Karaboué A, Giacchetti S, Bouchahda M, Adam R, Garufi C, Lévi F. Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial. Cancer Medicine 2020;9(12):4148 View
  7. Ballesta A, Innominato P, Dallmann R, Rand D, Lévi F, Watts S. Systems Chronotherapeutics. Pharmacological Reviews 2017;69(2):161 View
  8. De Rosa P, Jewell A. The potential use for patient reported outcome measures in people with pancreatic cancer, with a specific focus on older patients. European Journal of Surgical Oncology 2021;47(3):495 View
  9. Huang Q, Cohen D, Komarzynski S, Li X, Innominato P, Lévi F, Finkenstädt B. Hidden Markov models for monitoring circadian rhythmicity in telemetric activity data. Journal of The Royal Society Interface 2018;15(139):20170885 View
  10. Sultan A, Pati A, Choudhary V, Parganiha A. Hospitalization-induced exacerbation of the ill effects of chemotherapy on rest-activity rhythm and quality of life of breast cancer patients: a prospective and comparative cross-sectional follow-up study. Chronobiology International 2018;35(11):1513 View
  11. Komarzynski S, Huang Q, Innominato P, Maurice M, Arbaud A, Beau J, Bouchahda M, Ulusakarya A, Beaumatin N, Breda G, Finkenstädt B, Lévi F. Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study. Journal of Medical Internet Research 2018;20(6):e204 View
  12. Stéphanou A, Fanchon E, Innominato P, Ballesta A. Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why. Acta Biotheoretica 2018;66(4):345 View
  13. Beauchamp U, Pappot H, Holländer-Mieritz C. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review. JMIR mHealth and uHealth 2020;8(11):e22006 View
  14. Komarzynski S, Wreglesworth N, Griffiths D, Pecchia L, Subbe C, Hughes S, Davies E, Innominato P. Embracing Change: Learnings From Implementing Multidimensional Digital Remote Monitoring in Oncology Patients at a District General Hospital During the COVID-19 Pandemic. JCO Clinical Cancer Informatics 2021;(5):216 View
  15. Innominato P, Komarzynski S, Dallmann R, Wreglesworth N, Bouchahda M, Karaboué A, Ulusakarya A, Subbe C, Spiegel D, Lévi F. Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients. Supportive Care in Cancer 2021;29(11):6167 View
  16. Albino de Queiroz D, André da Costa C, Aparecida Isquierdo Fonseca de Queiroz E, Folchini da Silveira E, da Rosa Righi R. Internet of Things in active cancer Treatment: A systematic review. Journal of Biomedical Informatics 2021;118:103814 View
  17. Izmailova E, Wood W. Biometric Monitoring Technologies in Cancer: The Past, Present, and Future. JCO Clinical Cancer Informatics 2021;(5):728 View
  18. Arkandhi A, Harjaningsih W. Effectiveness of telemedicine use to improve patient outcome in cancer patients: A narrative review. Pharmacy Education 2022;22(2):248 View
  19. Amidi A, Wu L. Circadian disruption and cancer- and treatment-related symptoms. Frontiers in Oncology 2022;12 View
  20. Harris C, Pozzar R, Conley Y, Eicher M, Hammer M, Kober K, Miaskowski C, Colomer-Lahiguera S. Big Data in Oncology Nursing Research: State of the Science. Seminars in Oncology Nursing 2023;39(3):151428 View
  21. Bouchahda M, Ulusakarya A, Thirot-Bidault A, Attari A, Bossevot R, Tuligenga R, Hammel P, Adam R, Levi F. Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948). BMJ Open 2023;13(6):e069973 View
  22. Innominato P, Macdonald J, Saxton W, Longshaw L, Granger R, Naja I, Allocca C, Edwards R, Rasheed S, Folkvord F, de Batlle J, Ail R, Motta E, Bale C, Fuller C, Mullard A, Subbe C, Griffiths D, Wreglesworth N, Pecchia L, Fico G, Antonini A. Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study. JMIR Research Protocols 2024;13:e52957 View
  23. Urretavizcaya M, Álvarez K, Olariaga O, Tames M, Asensio A, Cajaraville G, Riestra A. Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology. European Journal of Hospital Pharmacy 2024:ejhpharm-2023-004072 View